ACS
DGX icon

Archford Capital Strategies’s Quest Diagnostics DGX Stock Holding History

Archford Capital Strategies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,136
Closed -$676K – 734
2014
Q3 		$676K Sell
11,136
-1,326
-11% -$81.7K 0.54% 65
2014
Q2 		$731K Buy
+12,462
New +$730K 0.57% 60

Other funds holding DGX

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Archford Capital Strategies's DGX Position: Q4 2014 in Review

Archford Capital Strategies sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 11,136 shares — an estimated $676K sold.

Archford Capital Strategies first reported a position in DGX in Q2 2014 and held it in 2 quarters. The position peaked at $731K in Q2 2014. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Archford Capital Strategies reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Archford Capital Strategies sold 11,136 Quest Diagnostics shares in Q4 2014, an estimated $676K.
  • Archford Capital Strategies first reported a position in Quest Diagnostics in Q2 2014 and held it in 2 quarters.
  • Archford Capital Strategies's Quest Diagnostics position peaked at $731K in Q2 2014.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Archford Capital Strategies's 13F filing for Q4 2014, filed 3 Feb 2015.